(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Super Micro Computer, MicroStrategy, and Aldeyra Therapeutics.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Super Micro Computer (SMCI) | 1128.21 | 24.6% | 2024-03-04 15:15:15 |
| 2 | MicroStrategy (MSTR) | 1332.64 | 23.46% | 2024-03-04 15:14:13 |
| 3 | Aldeyra Therapeutics (ALDX) | 4.22 | 16.57% | 2024-03-03 19:07:06 |
| 4 | Cara Therapeutics (CARA) | 1.09 | 14.74% | 2024-03-04 12:23:06 |
| 5 | Biolase (BIOL) | 0.16 | 14.13% | 2024-03-04 06:23:07 |
| 6 | Coinbase (COIN) | 234.04 | 13.74% | 2024-03-04 15:01:16 |
| 7 | bluebird bio (BLUE) | 1.56 | 12.59% | 2024-03-04 07:41:05 |
| 8 | Arrowhead Pharmaceuticals (ARWR) | 36.08 | 12.4% | 2024-03-03 23:10:06 |
| 9 | Rumble (RUM) | 7.20 | 9% | 2024-03-04 15:24:01 |
| 10 | KB Financial Group (KB) | 51.65 | 8.85% | 2024-03-04 15:56:13 |
The three biggest losers today are Kodak, Li Auto, and Beyond Meat.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Kodak (KODK) | 4.75 | -16.46% | 2024-03-04 15:56:25 |
| 2 | Li Auto (LI) | 37.67 | -13.47% | 2024-03-04 15:17:10 |
| 3 | Beyond Meat (BYND) | 8.55 | -12.54% | 2024-03-04 15:16:33 |
| 4 | Weibo (WB) | 8.41 | -7.99% | 2024-03-04 15:16:01 |
| 5 | Nio (NIO) | 5.32 | -7.96% | 2024-03-04 15:57:13 |
| 6 | Upland Software (UPLD) | 2.61 | -7.12% | 2024-03-04 15:15:45 |
| 7 | Sabre Corporation (SABR) | 2.43 | -7.09% | 2024-03-04 15:15:04 |
| 8 | Cogent Communications Holdings (CCOI) | 73.18 | -6.84% | 2024-03-04 15:09:06 |
| 9 | Tesla (TSLA) | 188.95 | -6.76% | 2024-03-04 15:10:50 |
| 10 | Codexis (CDXS) | 4.30 | -6.62% | 2024-03-04 15:23:06 |
Winners today
1. Super Micro Computer (SMCI) – 24.6%
Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.
NASDAQ ended the session with Super Micro Computer jumping 24.6% to $1,128.21 on Monday, after two consecutive sessions in a row of gains. NASDAQ slid 0.41% to $16,207.51, after two consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Super Micro Computer has a trailing twelve months EPS of $12.77.
PE Ratio
Super Micro Computer has a trailing twelve months price to earnings ratio of 88.35. Meaning, the purchaser of the share is investing $88.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.92%.
More news about Super Micro Computer.
2. MicroStrategy (MSTR) – 23.46%
MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions. The company also provides MicroStrategy Support that helps customers achieve their system availability and usage goals through highly responsive troubleshooting and assistance; MicroStrategy Consulting, which provides architecture and implementation services to help customers realize their desired results; and MicroStrategy Education that offers free and paid learning options. In addition, it engages in the development of bitcoin. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
NASDAQ ended the session with MicroStrategy rising 23.46% to $1,332.64 on Monday, after five successive sessions in a row of gains. NASDAQ slid 0.41% to $16,207.51, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, MicroStrategy has a trailing twelve months EPS of $26.45.
PE Ratio
MicroStrategy has a trailing twelve months price to earnings ratio of 50.38. Meaning, the purchaser of the share is investing $50.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.17%.
Yearly Top and Bottom Value
MicroStrategy’s stock is valued at $1,332.64 at 16:32 EST, way higher than its 52-week high of $1,080.00.
More news about MicroStrategy.
3. Aldeyra Therapeutics (ALDX) – 16.57%
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
NASDAQ ended the session with Aldeyra Therapeutics jumping 16.57% to $4.22 on Monday, following the last session’s upward trend. NASDAQ dropped 0.41% to $16,207.51, after two successive sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Aldeyra Therapeutics has a trailing twelve months EPS of $-0.78.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.04%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 36.4% and 48.1%, respectively.
Moving Average
Aldeyra Therapeutics’s value is way above its 50-day moving average of $3.36 and way below its 200-day moving average of $5.56.
Yearly Top and Bottom Value
Aldeyra Therapeutics’s stock is valued at $4.22 at 16:32 EST, way below its 52-week high of $11.97 and way higher than its 52-week low of $1.42.
Volatility
Aldeyra Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 3.87%, 1.58%, and 3.57%.
Aldeyra Therapeutics’s highest amplitude of average volatility was 5.92% (last week), 4.19% (last month), and 3.57% (last quarter).
More news about Aldeyra Therapeutics.
4. Cara Therapeutics (CARA) – 14.74%
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
NASDAQ ended the session with Cara Therapeutics rising 14.74% to $1.09 on Monday while NASDAQ slid 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Cara Therapeutics has a trailing twelve months EPS of $-2.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -86.16%.
Volume
Today’s last reported volume for Cara Therapeutics is 1336150 which is 42.95% above its average volume of 934643.
Yearly Top and Bottom Value
Cara Therapeutics’s stock is valued at $1.09 at 16:32 EST, way under its 52-week high of $10.28 and way above its 52-week low of $0.50.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 26.8% and 14.3%, respectively.
More news about Cara Therapeutics.
5. Biolase (BIOL) – 14.13%
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
NASDAQ ended the session with Biolase rising 14.13% to $0.16 on Monday while NASDAQ fell 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Biolase has a trailing twelve months EPS of $-150.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -254.96%.
Moving Average
Biolase’s worth is way below its 50-day moving average of $0.72 and way under its 200-day moving average of $3.76.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.1%, now sitting on 49.73M for the twelve trailing months.
Yearly Top and Bottom Value
Biolase’s stock is valued at $0.16 at 16:32 EST, way below its 52-week high of $49.00 and way higher than its 52-week low of $0.13.
Sales Growth
Biolase’s sales growth is negative 3.6% for the present quarter and 3.2% for the next.
More news about Biolase.
6. Coinbase (COIN) – 13.74%
Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase jumping 13.74% to $234.04 on Monday while NASDAQ slid 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $0.37.
PE Ratio
Coinbase has a trailing twelve months price to earnings ratio of 632.54. Meaning, the purchaser of the share is investing $632.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.74%.
Sales Growth
Coinbase’s sales growth is negative 49% for the ongoing quarter and negative 5.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coinbase’s EBITDA is 179.31.
Volatility
Coinbase’s last week, last month’s, and last quarter’s current intraday variation average was 1.63%, 2.67%, and 4.26%.
Coinbase’s highest amplitude of average volatility was 1.63% (last week), 5.87% (last month), and 4.26% (last quarter).
Yearly Top and Bottom Value
Coinbase’s stock is valued at $234.04 at 16:32 EST, way above its 52-week high of $187.39.
More news about Coinbase.
7. bluebird bio (BLUE) – 12.59%
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with bluebird bio rising 12.59% to $1.56 on Monday, following the last session’s upward trend. NASDAQ slid 0.41% to $16,207.51, after two successive sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, bluebird bio has a trailing twelve months EPS of $-0.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.81%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
bluebird bio’s EBITDA is -4.62.
More news about bluebird bio.
8. Arrowhead Pharmaceuticals (ARWR) – 12.4%
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in phase 2b clinical trial for the treatment of dyslipidemia; ARO-HSD, which is completed phase 1/2 clinical trial to treat liver diseases; ARO-ENaC2, which is in pre-clinical stage for the treatment of dyslipidemia cystic fibrosis; ARO-C3 that is in phase 1/2a clinical trial to reduce production of complement component 3; ARO-DUX4, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH that is in phase 1 clinical trial to treat uncontrolled gout; ARO-COV, which is in pre-clinical stage for the treatment of COVID-19; ARO-RAGE, which is in phase 1/2a clinical trial to treat muco-obstructive or inflammatory pulmonary conditions; and ARO-MMP7 that is in phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop JNJ-75220795, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.
NASDAQ ended the session with Arrowhead Pharmaceuticals rising 12.4% to $36.08 on Monday, following the last session’s upward trend. NASDAQ slid 0.41% to $16,207.51, after two sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Arrowhead Pharmaceuticals has a trailing twelve months EPS of $-2.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -106.24%.
Yearly Top and Bottom Value
Arrowhead Pharmaceuticals’s stock is valued at $36.08 at 16:32 EST, way below its 52-week high of $42.48 and way higher than its 52-week low of $20.67.
Volume
Today’s last reported volume for Arrowhead Pharmaceuticals is 2242380 which is 35.89% above its average volume of 1650120.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Arrowhead Pharmaceuticals’s EBITDA is 24.04.
Revenue Growth
Year-on-year quarterly revenue growth declined by 94.3%, now sitting on 181.74M for the twelve trailing months.
More news about Arrowhead Pharmaceuticals.
9. Rumble (RUM) – 9%
Rumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a subscription platform for creators and subscribers to engage through VOD, podcasts, live chat, polls, and community discussions; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.
NASDAQ ended the session with Rumble rising 9% to $7.20 on Monday, after four consecutive sessions in a row of gains. NASDAQ slid 0.41% to $16,207.51, after two sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Rumble has a trailing twelve months EPS of $-0.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.68%.
More news about Rumble.
10. KB Financial Group (KB) – 8.85%
KB Financial Group Inc. provides a range of banking and related financial services to consumers and corporations in South Korea and internationally. The company operates through seven segments: Retail Banking, Corporate Banking, Other Banking, Credit Card, Securities, Life Insurance, and Non-Life Insurance. It offers loans, deposit products, and other related financial products and services to large, small, and medium-sized enterprises, as well as individuals and households; investment banking, and brokerage and supporting services; life insurance products; non-life insurance products, including automobile, fire and allied lines, and marine insurance; bancassurance services; and credit sale, cash service, card loan, and other supporting services. The company also engages in securities and derivatives trading, funding, and other supporting activities. In addition, it offers foreign exchange transaction; financial investment; credit card and installment financing; financial leasing; real estate trust management; capital investment; collection of receivables or credit investigation; software advisory, development, and supply; investment advisory; claim; management; savings banking; information and communication; and general advisory services. The company was founded in 1963 and is headquartered in Seoul, South Korea.
NYSE ended the session with KB Financial Group jumping 8.85% to $51.65 on Monday while NYSE rose 0.12% to $17,750.08.
Earnings Per Share
As for profitability, KB Financial Group has a trailing twelve months EPS of $8.63.
PE Ratio
KB Financial Group has a trailing twelve months price to earnings ratio of 5.98. Meaning, the purchaser of the share is investing $5.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.41%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KB Financial Group’s stock is considered to be oversold (<=20).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Sep 28, 2023, the estimated forward annual dividend rate is 2.26 and the estimated forward annual dividend yield is 4.76%.
More news about KB Financial Group.
Losers Today
1. Kodak (KODK) – -16.46%
Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through four segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.
NYSE ended the session with Kodak sliding 16.46% to $4.75 on Monday, after two consecutive sessions in a row of gains. NYSE jumped 0.12% to $17,750.08, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Kodak has a trailing twelve months EPS of $0.69.
PE Ratio
Kodak has a trailing twelve months price to earnings ratio of 6.88. Meaning, the purchaser of the share is investing $6.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.79%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kodak’s EBITDA is 32.65.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kodak’s stock is considered to be oversold (<=20).
More news about Kodak.
2. Li Auto (LI) – -13.47%
Li Auto Inc., through its subsidiaries, designs, develops, manufactures, and sells new energy vehicles in the People's Republic of China. The company provides Li ONE and Li L series smart electric vehicles. It also offers sales and after sales management, and technology development and corporate management services, as well as purchases manufacturing equipment. The company offers its products through online and offline channels. The company was formerly known as Leading Ideal Inc. and changed its name to Li Auto Inc. in July 2020. Li Auto Inc. was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Li Auto sliding 13.47% to $37.67 on Monday, following the last session’s downward trend. NASDAQ slid 0.41% to $16,207.51, after two sequential sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Li Auto has a trailing twelve months EPS of $1.55.
PE Ratio
Li Auto has a trailing twelve months price to earnings ratio of 24.31. Meaning, the purchaser of the share is investing $24.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.33%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 136.4%, now sitting on 123.85B for the twelve trailing months.
More news about Li Auto.
3. Beyond Meat (BYND) – -12.54%
Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.
NASDAQ ended the session with Beyond Meat falling 12.54% to $8.55 on Monday, following the last session’s downward trend. NASDAQ fell 0.41% to $16,207.51, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Beyond Meat has a trailing twelve months EPS of $-5.26.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 16.2% and 13%, respectively.
More news about Beyond Meat.
4. Weibo (WB) – -7.99%
Weibo Corporation, through its subsidiaries, operates as a social media platform for people to create, distribute, and discover content in the People's Republic of China. It operates in two segments, Advertising and Marketing Services; and Value-Added Services. The company offers discovery products to help users discover content on its platform; self-expression products that enable its users to express themselves on its platform; and social products to promote social interaction between users on its platform. It also provides advertising and marketing solutions, such as social display advertisements; and promoted marketing offerings, such as Fans Headline and Weibo Express promoted feeds, as well as promoted trends and search products that appear alongside user's trends discovery and search behaviors. In addition, the company offers products, such as trends, search, video/live streaming, and editing tools; content customization, copyright contents pooling, and user interaction development; and search list recommendation, trends list recommendation, and Weibo app opening advertisements. Further, it provides back-end management, traffic support, and product solutions to MCNs, unions, and e-commerce partners; open application platform for other app developers that allows users to log into third-party applications with their Weibo account for sharing third-party content on its platform; and Weibo Wallet, a product that enables platform partners to conduct interest generation activities on Weibo, such as handing out red envelops and coupons. The company was formerly known as T.CN Corporation and changed its name to Weibo Corporation in 2012. The company was founded in 2009 and is headquartered in Beijing, China. Weibo Corporation operates as a subsidiary of Sina Corporation.
NASDAQ ended the session with Weibo dropping 7.99% to $8.41 on Monday, following the last session’s upward trend. NASDAQ dropped 0.41% to $16,207.51, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Weibo has a trailing twelve months EPS of $1.69.
PE Ratio
Weibo has a trailing twelve months price to earnings ratio of 4.98. Meaning, the purchaser of the share is investing $4.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.97%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Weibo’s EBITDA is 19.45.
More news about Weibo.
5. Nio (NIO) – -7.96%
NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.
NYSE ended the session with Nio dropping 7.96% to $5.32 on Monday, after two successive sessions in a row of gains. NYSE rose 0.12% to $17,750.08, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Nio has a trailing twelve months EPS of $-1.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.57%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nio’s stock is considered to be oversold (<=20).
More news about Nio.
6. Upland Software (UPLD) – -7.12%
Upland Software, Inc. provides cloud-based enterprise work management software in the United States, the United Kingdom, Canada, and internationally. It offers a family of software applications under the Upland brand in the areas of marketing, sales, contact center, project management, information technology, business operations, and human resources and legal. The company also provides professional services, such as implementation, data extraction, integration and configuration, and training services, as well as customer support services. It serves large global corporations, various government agencies, and small and medium-sized businesses, as well as financial, consulting, technology, manufacturing, media, telecommunication, political, healthcare, life sciences, and retail and hospitality sectors. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. Upland Software, Inc. was incorporated in 2010 and is headquartered in Austin, Texas.
NASDAQ ended the session with Upland Software sliding 7.12% to $2.61 on Monday, following the last session’s downward trend. NASDAQ dropped 0.41% to $16,207.51, after two successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Upland Software has a trailing twelve months EPS of $-5.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.09%.
Sales Growth
Upland Software’s sales growth for the current quarter is negative 4.1%.
More news about Upland Software.
7. Sabre Corporation (SABR) – -7.09%
Sabre Corporation, together with its subsidiaries, operates as software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates through two segments: Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. Its Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation sliding 7.09% to $2.43 on Monday while NASDAQ dropped 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.56.
Yearly Top and Bottom Value
Sabre Corporation’s stock is valued at $2.43 at 16:32 EST, under its 52-week low of $2.59.
Moving Average
Sabre Corporation’s value is way under its 50-day moving average of $3.98 and way below its 200-day moving average of $4.00.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 83.3% and 88.2%, respectively.
More news about Sabre Corporation.
8. Cogent Communications Holdings (CCOI) – -6.84%
Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Asia, South America, Australia, and Africa. The company offers on-net Internet access and private network services to law firms, financial services firms, and advertising and marketing firms, as well as heath care providers, educational institutions and other professional services businesses, other Internet service providers, telephone companies, cable television companies, Web hosting companies, media service providers, mobile phone operators, content delivery network companies, and commercial content and application service providers. It also provides Internet access and private network services to customers that are not located in buildings directly connected to its network; and on-net services to customers located in buildings that are physically connected to its network. In addition, the company offers off-net services to corporate customers using other carriers' circuits to provide the last mile portion of the link from the customers' premises to the network. Further, it operates data centers that allow its customers to collocate their equipment and access the network. The company operates 54 data centers and provides facilities to 3,035 buildings and on-net services to 1,817 to multi-tenant office buildings. It serves primarily to small and medium-sized businesses, communications service providers, and other bandwidth-intensive organizations. Cogent Communications Holdings, Inc. was founded in 1999 and is headquartered in Washington, the District of Columbia.
NASDAQ ended the session with Cogent Communications Holdings falling 6.84% to $73.18 on Monday while NASDAQ dropped 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Cogent Communications Holdings has a trailing twelve months EPS of $26.62.
PE Ratio
Cogent Communications Holdings has a trailing twelve months price to earnings ratio of 2.75. Meaning, the purchaser of the share is investing $2.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2801.11%.
Yearly Top and Bottom Value
Cogent Communications Holdings’s stock is valued at $73.18 at 16:32 EST, way below its 52-week high of $86.00 and way higher than its 52-week low of $57.35.
Moving Average
Cogent Communications Holdings’s worth is below its 50-day moving average of $75.92 and above its 200-day moving average of $67.82.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 923.1% and a negative 104.3%, respectively.
Sales Growth
Cogent Communications Holdings’s sales growth is 75.2% for the present quarter and 13% for the next.
More news about Cogent Communications Holdings.
9. Tesla (TSLA) – -6.76%
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.
NASDAQ ended the session with Tesla falling 6.76% to $188.95 on Monday while NASDAQ dropped 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Tesla has a trailing twelve months EPS of $4.3.
PE Ratio
Tesla has a trailing twelve months price to earnings ratio of 43.94. Meaning, the purchaser of the share is investing $43.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.35%.
Volatility
Tesla’s last week, last month’s, and last quarter’s current intraday variation average was 0.41%, 0.41%, and 1.92%.
Tesla’s highest amplitude of average volatility was 0.45% (last week), 2.01% (last month), and 1.92% (last quarter).
More news about Tesla.
10. Codexis (CDXS) – -6.62%
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
NASDAQ ended the session with Codexis dropping 6.62% to $4.30 on Monday while NASDAQ dropped 0.41% to $16,207.51.
Earnings Per Share
As for profitability, Codexis has a trailing twelve months EPS of $-1.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.89%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Codexis’s EBITDA is -4.91.
Volume
Today’s last reported volume for Codexis is 417780 which is 47.57% below its average volume of 796873.
More news about Codexis.
Stay up to date with our winners and losers daily report
